Cargando…
Personalized Medicine in Breast Cancer: A Systematic Review
The recent advent of "-omics" technologies have heralded a new era of personalized medicine. Personalized medicine is referred to as the ability to segment heterogeneous subsets of patients whose response to a therapeutic intervention within each subset is homogeneous. This new paradigm in...
Autores principales: | Cho, Sang-Hoon, Jeon, Jongsu, Kim, Seung Il |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Breast Cancer Society
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468779/ https://www.ncbi.nlm.nih.gov/pubmed/23091538 http://dx.doi.org/10.4048/jbc.2012.15.3.265 |
Ejemplares similares
-
Artificial Intelligence in Breast Cancer Diagnosis and Personalized Medicine
por: Ahn, Jong Seok, et al.
Publicado: (2023) -
Personalized medicine in breast cancer: pharmacogenomics approaches
por: Jeibouei, Shabnam, et al.
Publicado: (2019) -
Pharmacogenetics in breast cancer: steps toward personalized medicine in breast cancer management
por: Rofaiel, Sarah, et al.
Publicado: (2010) -
Chemotherapy for Lung Cancer in the Era of Personalized Medicine
por: Lee, Seung Hyeun
Publicado: (2019) -
Precision medicine and personalized breast cancer: combination pertuzumab therapy
por: Reynolds, Kerry, et al.
Publicado: (2014)